Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Ketamine for Comorbid PTSD and Chronic Pain
NCT04322968Phase 3Completed
- Sponsor
- VA Ann Arbor Healthcare System
- Start
- Jan 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in post-traumatic stress disorder (PTSD), chronic pain, sponsored by VA Ann Arbor Healthcare System. Started Jan 2018; status: completed.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)chronic pain
Beyond the preview
Go deeper on NCT04322968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322968.